It feeds on prebiotics like polyphenols and fiber to produce butyrate, which ultimately supports our bodys natural production of GLP-1, the hormone that helps regulate appetite and cravings (aka the hormone everyone is talking about these days as it relates to GLP-1 agonists)
Microbial Ecology, 75 (1), 228-238
As many adults are on a GLP-1 today as had ever tried one a year and a half ago
At the same time, pharmaceutical companies are putting serious money into R and D, trying to bring in next-generation therapies and make results more consistent for patients
Nodiarrhea affects approximately 20-25% of GLP-1 users, meaning the majority tolerate these medications without significant digestive disruption
They utilize osmotic pressure gradients generated by salt-based cores to drive drug release through semipermeable membranes, enabling precise kinetics independent of physiological conditions [48]